Items tagged as "trastuzumab"
ROCHESTER, Minnesota — 21 de enero de 2014 — Los científicos de Mayo Clinic descubrieron una amplificación de HER2, conocida por conducir a algunos cánceres de mama, en un tipo de cáncer de vejiga llamado carcinoma urotelial micropapilar (MPUC, por sus siglas en inglés), y demostraron que la presencia de [...]Created by Soledad Andrade
ROCHESTER, Minn. ― Jan. 21, 2014 ― Researchers at Mayo Clinic have found amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors. [...]Created by Sam Smith
In this Mayo Clinic Radio Health Minute, Dr. Edith Perez discusses recent research that may help determine treatment for some women with breast cancer. To listen, click the link below. Trastuzumab GeneticsCreated by Admin
Adding the drug trastuzumab to chemotherapy prevents cancer recurrence and improves survival in a majority of women with early stage HER2-positive breast cancer. But trastuzumab does not stop tumors from returning in about 25 percent of patients — and oncologists haven’t been able to identify these women before treatment. This [...]Created by Dana Sparks